Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 25696796.
- Also identified by DOI 10.1309/AJCPAPH28VHZEKNQ.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Accurate grading of gastrointestinal stromal tumors (GISTs), based on mitotic index, can be problematic. In this study, we compared interobserver variability in detecting mitosis on H&E with PHH3 immunohistochemistry (IHC). In addition, we examined the correlation between H&E mitosis and Ki-67 and the association of PHH3 and Ki-67 with overall survival. Four pathologists independently reviewed 50 GIST cases. Intraclass correlation coefficients showed good interobserver variability for mitotic counts on both H&E (0.918; 95% confidence interval [CI], 0.874-0.950) and PHH3 IHC (0.923; 95% CI, 0.882-0.953). Nineteen (38%) cases were graded higher and five (10%) cases were downgraded by at least one observer using PHH3 compared with H&E. Using receiver operating characteristic curve analysis, a PHH3 cutoff of seven or more mitoses was associated with worse overall survival (P = .028). Ki-67 showed poor correlation with H&E mitotic counts and overall survival (P = .077). PHH3 may thus be a valuable adjunct for risk stratification in GISTs.
Medical subject headings
- Biomarkers, Tumor
- Gastrointestinal Neoplasms
- Gastrointestinal Stromal Tumors
- Histones
- Ki-67 Antigen
- Mitotic Index